Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2Breast 1

Conditions

Colorectal Neoplasms 2Patient Preference 1Diabetes Mellitus 1Coronary Disease 1Breast Neoplasms 1

Interventions

Cyclophosphamide 548pembrolizumab 385Radiotherapy 363Bevacizumab 360Carboplatin 351Rituximab 315Cisplatin 300Gemcitabine 297Paclitaxel 288Dexamethasone 272Docetaxel 271fludarabine phosphate 241Doxorubicin 231Nivolumab 220Etoposide 209Cytarabine 203Lenalidomide 201fludarabine 191Oxaliplatin 191Fluorouracil 190Melphalan 189Filgrastim 188Capecitabine 175Calcium Dobesilate 172Radiosurgery 167Erlotinib Hydrochloride 167Methotrexate 163Bortezomib 162Granulocyte Colony-Stimulating Factor 154Whole-Body Irradiation 144

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Has results × Risk Assessment × Clear all
NCT01468675 2017-04-28

Health Information Technology (HIT) Enhanced Family History Documentation and Management in Primary Care

Brigham and Women's Hospital

Phase NA Completed
6,075 enrolled 5 charts
BreastGastrointestinal

Breast Neoplasms, Coronary Disease, Diabetes Mellitus, Colorectal Neoplasms

NCT01596582 2017-03-21

Risk Stratification to Promote Effective Shared Decision-Making for Colorectal Cancer Screening

Boston Medical Center

Phase NA Completed
352 enrolled 19 charts
Gastrointestinal

Colorectal Neoplasms, Patient Preference

Data powered by HemOnc (CC BY 4.0) Colophon âš¡